文献速递主动脉疾病

腹主动脉瘤腔内修复术后II型内漏的自然病史与治疗结局

Type II Endoleak after Endovascular Aneurysm Repair: Natural History and Treatment Outcomes.
PubMed 文献 · Ann Vasc Surg · 2017-05-05

该研究基于澳大利亚多中心693例EVAR患者,平均随访1.9年,225例发生II型内漏,其中133例自愈、37例未处理未愈、16例接受干预。吸烟和华法林为保护因素,年龄、右侧髂动脉迂曲及双侧髂外动脉直径为危险因素。全队列仅3例破裂,均发生于II型内漏患者,其中2例发生于再干预后且无瘤囊扩张,提示II型内漏伴瘤囊扩张与破裂无明显关联。

要点

  • II型内漏多数自愈,225例中133例自发消退。
  • 吸烟和华法林与II型内漏发生风险降低相关。
  • II型内漏伴瘤囊扩张未显示与破裂相关,破裂多无瘤囊扩张记录。

核心结论

  • 在本系列中,II型内漏患者发生动脉瘤破裂不常见。
  • II型内漏伴瘤囊扩张似乎与动脉瘤破裂无关。
  • 本系列中大多数动脉瘤破裂发生于无瘤囊扩张记录且再干预之后。

研究设计与样本

  • 研究为澳大利亚多中心回顾性队列,纳入2009至2013年693例接受EVAR的患者。
  • 比较发生II型内漏与II型内漏伴瘤囊扩张患者的术前人口学、死亡率、瘤囊扩张、破裂及干预率。
  • 平均随访1.9年(±1.0年)。

主要发现

  • 225例发生II型内漏,其中133例自发消退、37例未处理未消退、16例接受干预。
  • I型和III型内漏分别发生于50例和19例患者。
  • 吸烟(P=0.002)和华法林(P=0.044)为II型内漏的保护因素。
  • 年龄(P=0.034)、右侧髂动脉迂曲(P=0.031)、右侧(P=0.008)和左侧髂外动脉直径(P=0.028)为危险因素。
  • 全队列3例破裂均发生于II型内漏患者,其中2例发生于再干预后且无瘤囊扩张(>5 mm);有无II型内漏者生存无统计学显著差异。

关键数值与推荐

  • II型内漏自发消退133/225例,未处理未消退37例,干预16例。
  • 晚期II型内漏发生于117例,其中26例伴瘤囊扩张;无晚期II型内漏者中25例出现瘤囊扩张。
  • 干预后多数内漏消退(15/16例),8例有完整瘤囊尺寸随访信息者中0例出现瘤囊扩张。
  • 年龄(P<0.0001)和吸烟(P=0.001)为生存的显著独立预测因素。

临床怎么用

  • II型内漏多数可自发消退,可考虑观察等待。
  • 吸烟和华法林与II型内漏风险降低相关,年龄和髂动脉迂曲/直径与风险升高相关。
  • II型内漏伴瘤囊扩张与破裂关联不明显,再干预后仍需警惕破裂风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The natural history of type II endoleaks and linkage to aneurysm rupture is unclear. Likewise, treatment recommendations are controversial. The aim of this study was to examine the incidence, factors associated with type II endoleaks, and outcomes in an Australia cohort of patients who have undergone endovascular aneurysm repair (EVAR). METHODS: Data from 693 patients who underwent EVAR between 2009 and 2013 at multiple institutions across Australia were studied. Patients who developed (1) type II endoleak and (2) type II endoleak with sac expansion were compared for preoperative demographics, mortality, sac expansion, aneurysm rupture, and intervention rates. RESULTS: A total of 225 patients developed type II endoleak over a mean follow-up of 1.9 years (±1.0 years), out of which 133 spontaneously resolved, 37 were untreated unresolved, and 16 underwent intervention. Type I and III endoleaks occurred in 50 and 19 patients, respectively. Smoking (P = 0.002) and warfarin (P = 0.044) were protective factors for development of type II endoleak, whereas age (P = 0.034), right iliac artery tortuosity (P = 0.031), and right (P = 0.008) and left external iliac diameters (P = 0.028) were risk factors for endoleak. Three patients suffered aneurysm ruptures in the entire cohort. All ruptures occurred in type II endoleak patients, of which two occurred after reintervention and in the absence of sac expansion (>5 mm). Late type II endoleak occurred in 117 patients, out of which 26 had sac expansion. Of those without late type II endoleak, 25 have sac expansion. There was no statistically significant difference in survival between those with and without type II endoleak. Age (P < 0.0001) and smoking (P = 0.001) were significant independent predictive factors for survival in this patient sample. Treatment outcomes were encouraging with most cases involving endoleak resolution (15 of 16 patients) and no sac expansion after intervention (0 of 8 patients with complete follow-up info on sac size). CONCLUSIONS: Aneurysm rupture in patients with type II endoleak is uncommon in our series. Type II endoleak with sac expansion does not appear to be associated with aneurysm rupture. In this series, most aneurysm ruptures occurred in the absence of documented sac expansion and after reintervention.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Kumar L, Cowled P, Boult M, et al. Type II Endoleak after Endovascular Aneurysm Repair: Natural History and Treatment Outcomes. Ann Vasc Surg. 2017. PMID: 28483626. doi:10.1016/j.avsg.2017.04.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。